Seasonal Influenza Vaccine Effectiveness Study in Kenya
Seasonal Influenza Vaccine Effectiveness Study in the Kenyan Communities of Kibera and Lwak
Sponsor: Gideon Emukule
Listed as NCT01432340, this observational or N/A phase trial focuses on Influenza and Influenza Like Illness and remains completed. Sponsored by Gideon Emukule, it has been updated 12 times since 2010, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Oct 2024 — Present [monthly]
Completed
Status: Unknown → Completed
-
Sep 2024 — Oct 2024 [monthly]
Unknown
-
Jul 2024 — Sep 2024 [monthly]
Unknown
Status: Unknown Status → Unknown
-
Dec 2021 — Jul 2024 [monthly]
Unknown Status
-
Jan 2021 — Dec 2021 [monthly]
Unknown Status
▶ Show 7 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Unknown Status
-
Jun 2018 — Nov 2020 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Feb 2017 — Aug 2017 [monthly]
Unknown Status NA
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Jun 2010
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gideon Emukule
- Kenya Medical Research Institute
- Kenya Ministry of Health
- Sanofi Pasteur, a Sanofi Company
For direct contact, visit the study record on ClinicalTrials.gov .